(295) Prostatic Urethral Lift (PUL) is Superior to TURP in the Preservation of Ejaculatory Function in Patients with Obstructive Median Lobes (OML)

Abstract Introduction For the past several years, AUA has recommended PUL as a treatment option for eligible patients who desire preservation of erectile and ejaculatory function. Objective This analysis serves first detailed assessment sexual function symptom outcomes among treated with PUL, TURP or sham in controlled real-world studies PUL. Methods Outcomes including MSHQ bother scores were compared following groups through 12 months: 66 from L.I.F.T. pivotal RCT lateral lobe (LL) obstruction randomized to sham, 36 men LL BPH6 TURP, 45 OML MedLift, FDA-approved IDA extension LIFT trial. Patients large RWR study filtered approximate MedLift population results 187 MedLift. Results demonstrated superior only at all timepoints (Figure 1); 1- 3 months, subjects also experienced significantly better IPSS QoL improvement post-PUL TURP. was 170% greater than months; QoL, Qmax, BPHII improvements over same time period. IPSS, PVR equivalent 3-, 6-, months post-PUL; overall adverse events not elevated group. Conclusions Compared provides quicker during early post-operative period post-treatment OML. continues preserve BPH despite obstruction. Disclosure Yes, this is sponsored by industry/sponsor: Neotract, Inc./Teleflex Clarification Industry initiated, executed funded Any authors act consultant, employee shareholder an industry for: Inc./Teleflex.